pubmed-article:15380780 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:15380780 | lifeskim:mentions | umls-concept:C0021311 | lld:lifeskim |
pubmed-article:15380780 | lifeskim:mentions | umls-concept:C0020964 | lld:lifeskim |
pubmed-article:15380780 | lifeskim:mentions | umls-concept:C0023276 | lld:lifeskim |
pubmed-article:15380780 | lifeskim:mentions | umls-concept:C1514873 | lld:lifeskim |
pubmed-article:15380780 | pubmed:issue | 12 | lld:pubmed |
pubmed-article:15380780 | pubmed:dateCreated | 2004-9-21 | lld:pubmed |
pubmed-article:15380780 | pubmed:abstractText | Protective immunity against cutaneous leishmaniasis is dependent on the induction of Th1/Tc1 immune responses resulting in efficient parasite elimination. In this review, the mechanisms leading to protection are discussed with special focus on the role of Leishmania major-infected dendritic cells (DC) in induction of Th1-dependent immunity. Murine strain-dependent differences between DC derived from Leishmania-susceptible as compared to resistant mice are highlighted. | lld:pubmed |
pubmed-article:15380780 | pubmed:language | eng | lld:pubmed |
pubmed-article:15380780 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15380780 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:15380780 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:15380780 | pubmed:month | Oct | lld:pubmed |
pubmed-article:15380780 | pubmed:issn | 1286-4579 | lld:pubmed |
pubmed-article:15380780 | pubmed:author | pubmed-author:UdeyMark CMC | lld:pubmed |
pubmed-article:15380780 | pubmed:author | pubmed-author:von... | lld:pubmed |
pubmed-article:15380780 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:15380780 | pubmed:volume | 6 | lld:pubmed |
pubmed-article:15380780 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:15380780 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:15380780 | pubmed:pagination | 1102-9 | lld:pubmed |
pubmed-article:15380780 | pubmed:dateRevised | 2005-11-16 | lld:pubmed |
pubmed-article:15380780 | pubmed:meshHeading | pubmed-meshheading:15380780... | lld:pubmed |
pubmed-article:15380780 | pubmed:meshHeading | pubmed-meshheading:15380780... | lld:pubmed |
pubmed-article:15380780 | pubmed:meshHeading | pubmed-meshheading:15380780... | lld:pubmed |
pubmed-article:15380780 | pubmed:meshHeading | pubmed-meshheading:15380780... | lld:pubmed |
pubmed-article:15380780 | pubmed:meshHeading | pubmed-meshheading:15380780... | lld:pubmed |
pubmed-article:15380780 | pubmed:meshHeading | pubmed-meshheading:15380780... | lld:pubmed |
pubmed-article:15380780 | pubmed:meshHeading | pubmed-meshheading:15380780... | lld:pubmed |
pubmed-article:15380780 | pubmed:meshHeading | pubmed-meshheading:15380780... | lld:pubmed |
pubmed-article:15380780 | pubmed:meshHeading | pubmed-meshheading:15380780... | lld:pubmed |
pubmed-article:15380780 | pubmed:meshHeading | pubmed-meshheading:15380780... | lld:pubmed |
pubmed-article:15380780 | pubmed:year | 2004 | lld:pubmed |
pubmed-article:15380780 | pubmed:articleTitle | Requirements for Th1-dependent immunity against infection with Leishmania major. | lld:pubmed |
pubmed-article:15380780 | pubmed:affiliation | Department of Dermatology, Johannes Gutenberg-University, Langenbeckstrasse 1, D-55101 Mainz, Germany. vonstebu@mail.uni-mainz.de | lld:pubmed |
pubmed-article:15380780 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:15380780 | pubmed:publicationType | Review | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15380780 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15380780 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15380780 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15380780 | lld:pubmed |